8-K
Current Report
RIGEL PHARMACEUTICALS INC Filed Acc 0001104659-16-144763
Exit or restructuring costs · Executive or director change
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading a16-18575_18k.htm…